Evidence map›Paper›PMID 42039470›Full record

ArticlebioRxiv : the preprint server for biology2026

Calibration of in-frame indel variant effect predictors for clinical variant classification.

Haneen Abderrazzaq, Mugdha Singh, Larry Babb, Timothy Bergquist, Steven E Brenner, Vikas Pejaver, Anne O'Donnell-Luria, Predrag Radivojac, ClinGen Computational Working Group and ClinGen Variant Classification Working Group

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Haneen AbderrazzaqKhoury College of Computer Sciences, Northeastern University, Boston, Massachusetts, USA.ORCID 0009-0004-3554-1576
Mugdha SinghProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Larry BabbProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Timothy BergquistInstitute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-5614-8977
Steven E BrennerUniversity of California, Berkeley, CA, USA.ORCID 0000-0001-7559-6185
Vikas PejaverInstitute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-1943-0284
Anne O'Donnell-LuriaProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.ORCID 0000-0001-6418-9592
Predrag RadivojacKhoury College of Computer Sciences, Northeastern University, Boston, Massachusetts, USA.ORCID 0000-0002-6769-0793
ClinGen Computational Working Group and ClinGen Variant Classification Working Group

Funding

Baylor College of Medicine/Stanford University Clinical Genome Resource (CLINGEN)U24HG009649 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI TERI Ellen KLEIN, Aleksandar Milosavljevic · 2021 to 2026
$31.5M
The Clinical Genome Resource – Advancing genomic medicine through biocuration and expert assessment of genes and variants at scaleU24HG009650 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JONATHAN S BERG, Jessica Ezzell Hunter · 2021 to 2026
$30.0M
ClinGen AI Data Delivery SupplementU24HG006834 · NHGRI · BROAD INSTITUTE, INC. · PI Marina DiStefano, CHRISTA LESE MARTIN · 2021 to 2026
$26.7M
Joint Center for Mendelian GenomicsUM1HG008900 · NHGRI · BROAD INSTITUTE, INC. · PI O'DONNELL-LURIA, ANNE, REHM, HEIDI L · 2016 to 2020
$16.5M
Broad Institute Mendelian Genomic Research CenterU01HG011755 · NHGRI · BROAD INSTITUTE, INC. · PI Anne O'Donnell-Luria, MICHAEL E TALKOWSKI · 2021 to 2026
$14.6M
Center for Critical Assessment of Genome InterpretationU24HG007346 · NHGRI · UNIVERSITY OF CALIFORNIA BERKELEY · PI BRENNER, STEVEN E, IOANNIDIS, NILAH MONNIER · 2020 to 2025
$3.8M
Supporting IGVF by modeling genetics, function, and phenotype with machine learningU01HG012022 · NHGRI · NORTHEASTERN UNIVERSITY · PI Predrag Radivojac · 2021 to 2026
$3.4M
Systematic integration of variant interpretation tools into genetic and genomic risk predictionR01HG013350 · NHGRI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Vikas Rao Pejaver · 2024 to 2026
$1.7M
NHGRI NIH HHS R01 HG013350NHGRI NIH HHS U01 HG011755NHGRI NIH HHS U01 HG012022NHGRI NIH HHS U24 HG006834NHGRI NIH HHS U24 HG007346NHGRI NIH HHS U24 HG009649NHGRI NIH HHS U24 HG009650NHGRI NIH HHS UM1 HG008900
6 · The paper itself

Abstract

Insertions and deletions (indels) represent a substantial source of genetic variation in humans and are associated with a diverse array of functional consequences. Despite their prevalence and clinical importance, indels, particularly short in-frame indels, remain critically understudied compared to single nucleotide variants and are challenging to interpret clinically. While many computational predictors for missense variants have been rigorously evaluated and calibrated for clinical use, the clinical utility of tools for in-frame indels remains uncertain. To address this gap, we have calibrated in-frame indel prediction tools for clinical variant classification. We constructed a high-confidence dataset of in-frame indel variants (≤ 50bp) from clinical and population databases and estimated the prior probability of pathogenicity of a rare in-frame indel observed in a disease-associated gene, and of an insertion and deletion separately. Using a previously developed statistical framework based on local posterior probabilities, we then established score thresholds for eight computational tools, corresponding to distinct evidence levels for pathogenic and benign classification according to ACMG/AMP guidelines. All in-frame indel predictors evaluated here reached multiple evidence levels of pathogenicity and/or benignity, demonstrating measurable clinical value. However, these models consistently exhibited lower performance levels compared to missense predictors, highlighting the need for improved computational approaches for indel classification.

Identifiers

PMID42039470
PMCPMC13105015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.